What is ARS Pharmaceuticals, Inc.'s change in AP?

ARS Pharmaceuticals, Inc. (SPRY) reported change in AP of $10.32M in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s change in AP changed year-over-year?

ARS Pharmaceuticals, Inc.'s change in AP increased by 147.5% year-over-year, from $4.17M to $10.32M.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s change in AP?

Over 2 years (2022 to 2024), ARS Pharmaceuticals, Inc.'s change in AP has grown at a 26.3% compound annual growth rate (CAGR), from -$10.29M to $16.41M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

ARS Pharmaceuticals, Inc. SPRY Change in AP

Change in AP at other companies

Amneal Pharmaceuticals, Inc.AMRX

-$124.58M-10.6%

ViatrisVTRS

$32.7M-67.8%

AMP

Amphastar PharmaceuticalsAMPH

$9.6M-45.5%

Catalyst PharmaceuticalCPRX

-$4.05M+24.9%

Eton Pharmaceuticals, Inc.ETON

$2.51M+256%

Other financials

Income statement

See full

Revenue$22.7M+184%

Operating income-$60.1M-61.8%

Net income-$60.6M-78.6%

EPS (diluted)-$0.61-74.3%

Balance sheet

See full

Cash & equivalents$24.3M-39.0%

Total debt$96.5M+132,122%

Total equity$61.3M-73.2%

Total assets$287.6M-12.1%

Cash flow

See full

Operating cash flow-$44.9M-10.3%

CapEx--100%

Free cash flow-$44.9M-10.1%

Valuation

See full

Market cap$796.41M-48.7%

Enterprise value$868.61M-42.6%

P/S8.1×-7.9×

Profitability

See full

Operating margin-204.5%—

Net margin-200%-219pp

FCF margin-177.1%-206pp

Returns & leverage

See full

Return on equity-136.4%-144pp

Debt / equity1.6×+1.6×

Current ratio4.9×-6.1×

Where this comes from

Reported directly by ARS Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s change in AP?: ARS Pharmaceuticals, Inc. (SPRY) reported change in AP of $10.32M in Q1 2026.
How has ARS Pharmaceuticals, Inc.'s change in AP changed year-over-year?: ARS Pharmaceuticals, Inc.'s change in AP increased by 147.5% year-over-year, from $4.17M to $10.32M.
What is the long-term trend for ARS Pharmaceuticals, Inc.'s change in AP?: Over 2 years (2022 to 2024), ARS Pharmaceuticals, Inc.'s change in AP has grown at a 26.3% compound annual growth rate (CAGR), from -$10.29M to $16.41M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.